Skip to main content

Select Drug Profiles

FDA Approvals
Promising Oncology Drugs in the Pipeline
Caroline Helwick
Read More
Practice Management
Accountable Care Organizations in the Era of Healthcare Reform
Read More
Practice Management
The New Accountable Care Organizations and Medicare Gain-Sharing Program
Kip Piper, MA, FACHE
Read More
Practice Management
The Impact of Healthcare Reform on Payers’ Products, Provider Reimbursement, and Member Engagement
Sam Muppalla, Robert Capobianco
Read More
Practice Management
Enhanced Generic Utilization Saved US Healthcare $139.6 Billion in 2009
Dalia Buffery, MA, ABD
Read More
Practice Management
The Current State of Bundled Payments
Jim Evans
Read More
Practice Management
Expect the Unexpected: A Role for Behavioral Economics in Understanding the Impact of Cost- Sharing on Emergency Department Utilization
Albert Tzeel, MD, MHSA, CPE, FAAPL, Jack Brown, BA
Stakeholder Perspective
by Alberto M. Colombi, MD, MPH
Read More
Original Research
Effectiveness of Anti-Tumor Necrosis Factor Agents in the Treatment of Rheumatoid Arthritis: Observational Study
Anna D’Souza, PhD, Brian L. Meissner, PharmD, PhD, Boxiong Tang, MD, PhD, Scott McKenzie, MD, Catherine T. Piech, MBA
Stakeholder Perspective
Effectiveness of Anti-TNFs in Patients with RA, and Coverage Considerations
by Matthew Mitchell, PharmD, MBA, FAMCP
Read More
Practice Management
Comparing Medical Cost of Care for Patients with Metastatic Breast Cancer Receiving Taxane Therapy: Claims Analysis
Rex W. Force, PharmD, Brooke A. Pugmire, PharmD, Vaughn L. Culbertson, PharmD
Stakeholder Perspective
Can We Afford Improved Clinical Outcomes?
by Atheer A. Kaddis, PharmD
Read More
Practice Management
Use of Comparative Effectiveness Analysis in Managed Care
Gene Reeder, RPh, PhD, Timothy S. Regan, BPharm, RPh, CPh
Read More
Page 225 of 244
Results 2241 - 2250 of 2434